Log in to search using one of your social media accounts:

 

Lymphadenectomy Boosts Survival in Stage I Node-negative Endometrial Cancer Lymphadenectomy Boosts Survival in Stage I Node-negative Endometrial Cancer
Pelvic and para-aortic lymphadenectomy are associated with increased survival in women with stage I node-negative endometrioid endometrial cancer, new research suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 25, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Medical News Today: Endometrial cancer: Potential new target for resistant tumors found
Targeting the surface protein CD55 in cancer stem cells may offer a new route to overcoming chemo-resistance in endometrioid tumors, a new study suggests. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 25, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Researchers discover cancer stem cell pathway in endometrial cancer
(Cleveland Clinic) A team of Cleveland Clinic researchers have discovered a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much needed new therapies for women with limited options. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 24, 2017 Category: Cancer & Oncology Source Type: news

'Junk food' may increase cancer risk in 'healthy weight' women
"Women who eat junk food such as burgers or pizza are increasing their risk of cancer even if they're not overweight, new research has warned," reports the Daily Mail. The story is based on research from the US looking at the diet of postmenopausal women in the 1990s and then tracking the development of a variety of cancers over about 15 years. "Junk food" is often defined as food that is rich in calories (energy dense food) but low in nutrients. Having a diet high in energy dense foods, such as biscuits, chocolate and pizza was found to increase the risk of cancer in these women, specifically in those ...
Source: NHS News Feed - August 18, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

For post-menopausal women, vaginal estrogens do not raise risk of cancer, other diseases
This study, the first to examine potential adverse health effects in users of vaginal estrogen compared with non-users, suggests that vaginal estrogen therapy is a safe treatment for genitourinary symptoms such as burning, discomfort, and pain during intercourse associated with menopause.AUTHORSThe paper ’s authors are Dr. Carolyn Crandall of UCLA; Kathleen Hovey of the State University of New York at Buffalo; Christopher Andrews of the University of Michigan; Dr. Rowan Chlebowski of City of Hope; Marcia Stefanick of Stanford University; Dr. Dorothy Lane of the State University of New York at Ston y Brook; Dr. Jan Sh...
Source: UCLA Newsroom: Health Sciences - August 16, 2017 Category: Universities & Medical Training Source Type: news

Endometrial Ablation Doesn ’ t Increase Cancer Risk
No increased risk of endometrial, breast cancer for women in Finland treated with endometrial ablation (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 14, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

Preston woman learns she has endometrial cancer
Vaishali Bamania, of Preston, was diagnosed after years of irregular periods. She admits she would have ignored her symptoms if she had not been trying for a baby with husband Rahul. (Source: the Mail online | Health)
Source: the Mail online | Health - August 14, 2017 Category: Consumer Health News Source Type: news

Lynch Syndrome Studies Highlight Screening, Surveillance Opportunities
Two studies on Lynch syndrome highlight cancer screening and surveillance opportunities. (Source: CancerNetwork)
Source: CancerNetwork - August 13, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Endometrial Cancer Gastrointestinal Cancer Gynecologic Cancers News Ovarian Cancer Source Type: news

Women warned to avoid CADMIUM intake to prevent endometrial cancer
(Natural News) A five-year observational study that was recently published in PLOS ONE found that women who have in their bodies increased levels of cadmium – a metal that is obtained from foods like kidneys, liver, and shellfish, and also tobacco – are more prone to incurring endometrial cancer, which results from an abnormal growth of... (Source: NaturalNews.com)
Source: NaturalNews.com - August 12, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Cadmium may raise risk of endometrial cancer
A case-control study of 1,510 women found that the risk of endometrial cancer was 22 percent higher in those with higher levels of cadmium. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 11, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Cadmium Linked With Increased Endometrial Cancer Rates
Women with increased levels of cadmium, which mimics estrogen in the body, had a higher risk of endometrial cancer, according to a recently published observational study. (Source: CancerNetwork)
Source: CancerNetwork - August 9, 2017 Category: Cancer & Oncology Authors: Ian Ingram Tags: Endometrial Cancer Gynecologic Cancers News Source Type: news

Increased endometrial cancer rates found in women with high levels of cadmium
(University of Missouri-Columbia) Through a five-year observational study recently published in PLOS One, researchers at the University of Missouri found that women with increased levels of cadmium -- a metal commonly found in foods such as kidneys, liver and shellfish as well as tobacco -- also had an increased risk of endometrial cancer. It's an observation the researchers hope could lead to new treatments or interventions to prevent the fourth most common cancer in women. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2017 Category: International Medicine & Public Health Source Type: news

In assessing risk of hormone therapy for menopause, dose — not form — matters
FINDINGSWhen it comes to assessing the risk of estrogen therapy for menopause, how the therapy is delivered — taking a pill versus wearing a patch on one’s skin — doesn’t affect risk or benefit, researchers at UCLA and elsewhere have found. But with the commonly used conjugated equine estrogen, plus progestogen, the dosage does. Higher doses, especially over time, are associated with greater risk of problems, including heart disease and some types of cancer, especially among obese women.BACKGROUNDThe Women ’s Health Initiative established the potential of estrogen therapy to increase or decrea...
Source: UCLA Newsroom: Health Sciences - July 27, 2017 Category: Universities & Medical Training Source Type: news

Mayo Investigator Is Developing A Screening Test For Endometrial Cancer
This article is authored by the Mayo Clinic Center for Individualized Medicine. The mission of the Center is to discover (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - June 28, 2017 Category: Consumer Health News Source Type: news

Xenetic Biosciences enrols first patient in Phase II trial of XBIO-101 for endometrial cancer
US-based biopharmaceutical firm Xenetic Biosciences has started patient enrolment in its Phase II clinical trial of XBIO-101 (sodium cridanimod) and progestin therapy combination to treat patients with endometrial cancer. (Source: Drug Development Technology)
Source: Drug Development Technology - June 26, 2017 Category: Pharmaceuticals Source Type: news

Endometrial Cancer Patients Not Offered Genetic Counseling Referrals
According to a study recently presented at the 2017 American Society of Clinical Oncology Annual Meeting, held June 2 –6 in Chicago, women diagnosed with endometrial cancer are oftentimes not provided with genetic counseling referrals. (Source: CancerNetwork)
Source: CancerNetwork - June 19, 2017 Category: Cancer & Oncology Authors: Lori Smith, MSN, BSN, CRNP Tags: News Oncology Nursing Gynecologic Cancers Source Type: news

Study helps identify a way for robotic surgery to stage endometrial cancer in a less invasive manner
A minimally-invasive procedure known as sentinel lymph node mapping accurately can determine the stage of endometrial cancer, according to new research that TriHealth contributed to that recently was published in The Lancet Oncology. One of the onerous experiences of cancer diagnosis can be the intrusive surgery required to accurately determine the stage to which the disease has progressed. This new study shows, through robotic surgery, doctors can take out fewer lymph nodes and find the cancer… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 17, 2017 Category: Biotechnology Authors: Dr. Kevin Schuler Source Type: news

Study helps identify a way for robotic surgery to stage endometrial cancer in a less invasive manner
A minimally-invasive procedure known as sentinel lymph node mapping accurately can determine the stage of endometrial cancer, according to new research that TriHealth contributed to that recently was published in The Lancet Oncology. One of the onerous experiences of cancer diagnosis can be the intrusive surgery required to accurately determine the stage to which the disease has progressed. This new study shows, through robotic surgery, doctors can take out fewer lymph nodes and find the cancer… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 17, 2017 Category: Health Management Authors: Dr. Kevin Schuler Source Type: news

Womb cancer symptoms - five signs YOU could have cancer of the uterus
WOMB cancer - also known as uterine, uterus or endometrial cancer - is the fourth most common cancer in women in the UK. (Source: Daily Express - Health)
Source: Daily Express - Health - June 8, 2017 Category: Consumer Health News Source Type: news

10 Facts Women Should Know About Endometrial Cancer
The most common cancer of the reproductive organs in American women is endometrial cancer. The American Cancer Society estimates that for the year 2017, around 61,380 new cases of cancer of the body of the uterus will be diagnosed and about 10,920 women will die from cancers of the uterine body. These figures include both endometrial cancers and uterine sarcomas. Since endometrial cancer is a fairly common cancer in women, the more women know the facts about this disease, the greater their chance of knowing what symptoms to be aware of in order to have it diagnosed as early as possible, improving the likelihood of surviva...
Source: Healthy Living - The Huffington Post - June 5, 2017 Category: Consumer Health News Source Type: news

Breastfeeding lowers endometrial cancer risk, study says
Australian researchers found that women who breastfed their children were 11 percent less likely than women who didn't breastfeed to be diagnosed with endometrial cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2017 Category: Consumer Health News Source Type: news

Breastfeeding linked to lower endometrial cancer risk
(Reuters Health) - Women who breastfeed their babies for the recommended six months may also be lowering their own risk of developing endometrial cancer, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - June 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Bariatric Surgery Reduces Female-Specific Cancers Bariatric Surgery Reduces Female-Specific Cancers
Bariatric surgery reduces the incidence of female-specific cancers, especially endometrial cancer, in obese women.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 29, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Expanding waistline linked to an increased risk of cancer
Conclusion This study provides more evidence of the link between excess body fat and 10 cancers. Though the percentage increases sound large, it's important to put these results into context. For example, the baseline risk of postmenopausal cancer was 2.2% – it occurred in 555 of the 24,751 women in the study. For women who hadn't used hormone therapy, this would increase to a risk of 2.7% if they had a BMI of 30 compared with 26, or a waist circumference of 95cm compared with 84cm. This accounts for only an extra 5 cases in every 1,000 women. This large study involved older adults from European countries, so ...
Source: NHS News Feed - May 25, 2017 Category: Consumer Health News Tags: Cancer Obesity Source Type: news

Your NEJM Group Today: Letter to a Young Female Physician / Breast-Feeding & Endometrial Cancer / California Primary Care Opportunities (FREE)
By the Editors Here's what we chose for you from NEJM Group today:NEJM Clinical Practice Center: Perspective: There is sexism in medicine, but there may also be a more insidious obstacle. … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 19, 2017 Category: Primary Care Source Type: news

POINT: Is Lymphadenectomy Required in Endometrial Cancer for Adequate Surgical Staging?
The diagnostic benefits of SLN evaluation include an ability to identify the extent of tumor dissemination and the utility of SLN mapping in guiding targeted adjuvant treatment in high-risk patients. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2017 Category: Cancer & Oncology Authors: Andrea Mariani, MD Francesco Multinu, MD Jvan Casarin, MD Tags: Endometrial Cancer Gynecologic Cancers Oncology Journal Source Type: news

COUNTERPOINT: Is Lymphadenectomy Required in Endometrial Cancer for Adequate Surgical Staging?
The question that should be posed to those who advocate for lymphadenectomy as a tool to guide the adjuvant therapy of endometrial cancer is: At what cost to the patient is lymphadenectomy performed? (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2017 Category: Cancer & Oncology Authors: Emma Rossi, MD Tags: Endometrial Cancer Gynecologic Cancers Oncology Journal Source Type: news

NHGRI researchers home in on mutation profiles of clear cell endometrial cancer
(NIH/National Human Genome Research Institute) NHGRI researchers and their collaborators identify mutations in the TAF1   gene in clear cell endometrial cancer (CCEC) tumors; shed light on the underlying genomic changes that are likely to be important in driving development of this a rare but clinically aggressive form of endometrial cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2017 Category: Cancer & Oncology Source Type: news

Aeterna shares tumble after cancer-killing agent fails in Phase III trial
Shares in Aeterna Zentaris (NSDQ:AEZS) fell more than -50% this morning after the company said that the Phase III trial of Zoptrex did not meet its primary endpoint in women with locally advanced, recurrent or metastatic endometrial cancer. The ZoptEC pivotal trial was designed to evaluate the safety and efficacy of a hybrid molecule made up of a synthetic peptide carrier and doxorubicin. Researchers randomized 512 patients to receive either Zoptrex or doxorubicin intravenously every 3 weeks for up to 9 cycles. Get the full story at our sister site, Drug Delivery Business News. The post Aeterna shares tumble...
Source: Mass Device - May 1, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Wall Street Beat Women's Health Aeterna Zentaris Source Type: news

Hysterectomy and cancer – Judith ’ s story
The post Hysterectomy and cancer – Judith’s story appeared first on Hysterectomy Association. My story starts in the middle of 2010 when I started having increased frequency in my periods and by November 2010 they had become unbearable with flooding, which was getting to the point of interrupting with my home and work life. My colleagues at work kept losing me and I had to carry a change of clothes with me wherever I went. At this point I went to the GP and asked for a gynaecologist referral, which thankfully because of having a good Dr she agreed to refer me. I struggled on and early Jan 2011 I had the first o...
Source: The Hysterectomy Association - April 25, 2017 Category: OBGYN Authors: Linda Tags: Your Stories bilateral salpingo oophorectomy endometrial cancer total abdominal hysterectomy Source Type: news

Hypertension May Positively Affect Ovarian Cancer Prognosis
Linked to 46 percent lower risk of progression for women with endometrioid ovarian cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 20, 2017 Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Journal, Source Type: news

Endometrial cancer: clinical review
Risk factors for endometrial cancer, management options, conducting a physical examination, prognosis and follow-up. (Source: GP Online Education)
Source: GP Online Education - April 5, 2017 Category: Primary Care Tags: 10.1 Women's Health Source Type: news

PET identifies cell mutations in NSCLC patients
With the help of FDG-PET and an advanced image analysis technique known as...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT can direct biopsies for pediatric cancer PET/CT remains best option for head, neck cancer FDG-PET/CT targets metastases in cervical, endometrial cancer ASTRO: Negative PET/CT doesn't always mean dormant NSCLC (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 4, 2017 Category: Radiology Source Type: news

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA
Equivalent disease - free survival at 4.5 years for stage I endometrial cancer with TAH, TLH (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 29, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Journal, Source Type: news

Less invasive hysterectomy for early-stage endometrial cancer finds clinical support
Researchers found similar rates of disease-free survival and no difference in overall survival among women who received a laparoscopic or abdominal total hysterectomy for stage I endometrial cancer, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 28, 2017 Category: Science Source Type: news

Findings support use of less invasive hysterectomy for early-stage endometrial cancer
(The JAMA Network Journals) Researchers found similar rates of disease-free survival and no difference in overall survival among women who received a laparoscopic or abdominal total hysterectomy for stage I endometrial cancer, according to a study published by JAMA. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 28, 2017 Category: Cancer & Oncology Source Type: news

Mangosteen: The Cancer-Fighting Superfruit
  If you're a woman with a family history of breast cancer, your doctor may recommend you start taking a toxic chemo drug like tamoxifen to lower your risk of developing the disease. Even if you have no signs or symptoms of cancer. Tamoxifen is what's known as a chemopreventive agent. That's a fancy phrase that means it's something that prevents cancer from forming. But its track record isn't all that impressive. Trials found that for every 1,000 women who take the drugs, only 21 to 35 cases of cancer would be prevented. And the side effects are downright terrifying. Bone pain, blood clots, increas...
Source: Al Sears, MD Natural Remedies - March 23, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

TransEnterix adds hernia repair to Senhance robotic surgical platform
TransEnterix (NYSE:TRXC) said today it is looking to expand the use of its Senhance robotic surgical system to include hernia repair surgeries, touting that the system has been used in for the 1st time in such procedures in Germany. Research Triangle Park, N.C.-based Transenterix said that Dr. Dietmar Stephan and Dr. Frank Willeke performed up to 3 hernia surgeries with the robotic platform per day during the system’s 1st weeks of clinical use at the St. Marien-Krankenhaus Siegen hernia repair center in Germany. “We are pleased to offer robotic hernia repair utilizing the Senhance Robotic Sy...
Source: Mass Device - March 22, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Robot-Assisted Surgery Robotics Surgical TransEnterix Source Type: news

The pill provides 'lifelong protection against some cancers'
Conclusion The research is in line with other studies that have reported on cancer risk and the pill. This study had the advantage of being both very large and having the longest follow-up period of any study of the effects of the pill on cancer. But we shouldn't lose sight of this study's limitations. It's not possible to say that taking the pill prevented women from getting certain cancers. It may be the case, but other confounding factors could be involved. The researchers took account of some basic factors that affect cancer risk, but not others like diet, physical exercise, weight and alcohol use. Many of the...
Source: NHS News Feed - March 22, 2017 Category: Consumer Health News Tags: Cancer Medication Pregnancy/child Source Type: news

' First in human' trial defines safe dosage for small molecule drug ONC201 for solid cancer tumors
A ‘first in human’ clinical trial examining the small molecule drug ONC201 in cancer patients with advanced solid tumors shows that this investigational drug is well tolerated at the recommended phase II dose. That’s according to investigators whose research also showed early signs of clinical b enefit in patients with advanced prostate and endometrial cancers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 22, 2017 Category: Science Source Type: news

Galena reports positive results from Phase I/IIa cancer trial of GALE-301
US-based biopharmaceutical firm Galena Biopharma has reported positive final results from the Phase I/IIa clinical trial of GALE-301 (E39) to prevent recurrence of ovarian and endometrial cancer. (Source: Drug Development Technology)
Source: Drug Development Technology - March 21, 2017 Category: Pharmaceuticals Source Type: news

FDG-PET/CT can direct biopsies for pediatric cancer
FDG-PET/CT can play a valuable role in directing image-guided biopsies of pediatric...Read more on AuntMinnie.comRelated Reading: PET/CT remains best option for head, neck cancer FDG-PET/CT targets metastases in cervical, endometrial cancer FDG-PET/CT aids assessment of lower-stage breast cancer PET/CT after therapy avoids surgery for head, neck cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 8, 2017 Category: Radiology Source Type: news

Wide range of cancers now linked to being overweight
Conclusion The results of this study provide further evidence for the link between increasing levels of fat and the risk of developing certain cancers. There was strong evidence for nine cancers, with another two – ovarian cancer and stomach cancer – included when comparing obesity with healthy weight. This study is important in showing the significance of fat levels and obesity in cancer risk. But there are some important things to consider: The study doesn't tell us how excess body fat might play a role in the development of certain cancers, just that there's a link. Some studies might have been missed,...
Source: NHS News Feed - March 1, 2017 Category: Consumer Health News Tags: Cancer Obesity Source Type: news

TransEnterix shares dip despite 1st sale in Germany
Shares in TransEnterix (NYSE:TRXC) have dipped today despite the robotic surgical maker announcing yesterday that it landed the 1st sale of the system in Germany. The Research Triangle, N.C.-based company sold the 1st Senhance surgical system in the country to St. Marien-Krankenhaus Siegen. The hospital said it will use the device to establish a robotic surgical program that will initially focus on general and gynecologic surgery. “We chose the Senhance to bring robotic surgical assistance to the treatment of our patients. The combination of robotic precision, advanced visualization, and haptic technology a...
Source: Mass Device - February 24, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Robot-Assisted Surgery Robotics TransEnterix Source Type: news

Sentinel Lymph Node Biopsy'Sufficient' in Endometrial Cancer Sentinel Lymph Node Biopsy'Sufficient' in Endometrial Cancer
The largest study to date showed that sentinel lymph node biopsy is as accurate as full lymph node dissection in early endometrial cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

T2D's Tie to Pancreatic Ca: Oncotherapy Network & Cancer Network
(MedPage Today) -- Also, intentional weight loss may lower endometrial cancer risk (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 15, 2017 Category: American Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for February 14, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Medical device’s biggest players doled out $895m to docs in 2015 The 25 largest medical device companies paid out a collective $894.6 million in general and research fees to doctors in 2015, according to data from the Cen...
Source: Mass Device - February 14, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

TransEnterix touts French debut for Senhance robot-assisted surgery device
TransEnterix (NYSE:TRXC) yesterday touted the 1st clinical use in France of its Senhance robot-assisted surgery platform. The 1st French case, performed by Dr. Celine Chauleur of CHU Saint-Ètienne, was a hysterectomy to treat endometrial cancer with pelvic lymphadenectomy Feb. 7. The patient was discharged less than 24 hours after surgery, Toronto-based TransEnterix said. “I am very pleased to now offer Senhance surgery to my patients for the treatment of gynecologic cancers,” Chauleur said in prepared remarks. “As a minimally invasive surgeon, I appreciate the precision and control ...
Source: Mass Device - February 14, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Robot-Assisted Surgery Wall Street Beat Women's Health TransEnterix Source Type: news

Intentional Weight Loss Linked to Lowered Endometrial Cancer Risk
Intentional weight loss can lower the risk of endometrial cancer in postmenopausal women, according to a new study. This was especially true of obese women who lost weight. (Source: CancerNetwork)
Source: CancerNetwork - February 7, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Endometrial Cancer Gynecologic Cancers News Source Type: news